Table 4.
SAEs according to treatment group
| SAEs | NIAT-Rituximab Group, n=37 | NIAT Group, n=38 | P Value |
|---|---|---|---|
| No. of events | 0.87 | ||
| 0 | 31 | 33 | |
| 1 | 5 | 4 | |
| ≥2 | 1 | 1 | |
| Event details | |||
| Acute renal failurea | 0 | 2 | |
| Infection | |||
| Prostatitis | 1 | 0 | |
| Pleural effusiona | 0 | 1 | |
| Cardiac and vascular disorders | |||
| Myocardial infarction | 1 | 1 | |
| Critical limb ischemia | 0 | 1 | |
| Mesenteric ischemiab | 1 | 0 | |
| Carotid endarteriectomyb | 1 | 0 | |
| Aortoiliac femoral bypassb | 1 | ||
| Cancera | 0 | 1 | |
| Others | |||
| Edema | 1 | 1 | |
| Pain and fever | 1 | 0 | |
| Diarrhea | 1 | 0 | |
| Asthma | 0 | 1 |
Data are shown as n.
a
These SAEs occurred in the same patient.
b
These SAEs occurred in the same patient.